Clin Mol Hepatol.  2025 Apr;31(2):e183-e185. 10.3350/cmh.2025.0152.

The burden of steatotic liver disease before and during the COVID-19 pandemic: Correspondence to editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023”

Affiliations
  • 1Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA
  • 2Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA
  • 3Division of Gastroenterology and Hepatology, Department of Medicine, University of Arizona College of Medicine, Phoenix, AZ, USA
  • 4Division of Gastroenterology and Hepatology, Department of Internal Medicine, Banner University Medical Center, Phoenix, AZ, USA
  • 5Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA
  • 6Division of Gastroenterology and Epidemiology, University of California at San Diego, La Jolla, CA, USA

Keyword

MASLD; COVID-19; SLD; NAFLD
Full Text Links
  • CMH
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr